Recombinant Human PISD Protein，His

Pseudomonas aeruginosa is a common opportunistic pathogen responsible for various infections, particularly in immunocompromised patients. One of the key factors contributing to its virulence is the presence of proteinase inhibitors, such as PISD (Pseudomonas Inhibitor of Serine Proteases D), which play a significant role in the bacterium's ability to evade host immune responses. Research on the PISD protein has gained traction due to its potential utility in therapeutic applications and as a target for novel antimicrobial strategies. Understanding the structure, function, and mechanisms of PISD can provide insights into its role in bacterial pathogenicity and immune evasion. Studies have demonstrated that PISD can inhibit various serine proteases, which are crucial in the activation of immune pathways. By exploring the biochemical properties and interactions of PISD with its substrates, researchers aim to elucidate the molecular pathways involved in bacterial resistance, which may pave the way for the development of innovative treatments against Pseudomonas infections. Moreover, characterizing PISD's structure could lead to the design of specific inhibitors that may assist in enhancing host defense mechanisms or restoring susceptibility to conventional antibiotics. This area of research is particularly relevant in the context of rising antibiotic resistance, making the exploration of protein-based approaches to combat infections a pressing imperative in modern medicine. Consequently, PISD not only serves as a fascinating subject for fundamental microbiological research but also represents a promising avenue for translational applications in the fight against antibiotic-resistant pathogens.